Utilizing Targeted Biologic Therapies to Address the Overuse of Oral Corticosteroids in the Management of Severe Asthma (ID: i736a) Survey

Question Title

* 1. How many patients with severe asthma do you currently manage in your practice? Please respond with your best approximate number.

Question Title

* 2. How many years have you been in practice?

1-10

11-20

≥21

Question Title

* 3. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information that I can apply to my area of practice.

I need more information before I change my practice behavior.

This activity will not change my practice, as my current practice is consistent with the information presented.

This activity will not change my practice, as I do not agree with the information presented.

Question Title

* 4. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes.

Question Title

* 5. As a result of your participation in this activity, what strategies/changes do you plan to implement in your practice?

Question Title

* 6. What barriers do you see to making changes in your practice?

Question Title

* 7. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 8. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Utilize available clinical guidelines to accurately diagnose patients with severe asthma vs difficult-to-treat asthma vs uncontrolled persistent asthma	Utilize available clinical guidelines to accurately diagnose patients with severe asthma vs difficult-to-treat asthma vs uncontrolled persistent asthma Strongly agree	Utilize available clinical guidelines to accurately diagnose patients with severe asthma vs difficult-to-treat asthma vs uncontrolled persistent asthma Agree	Utilize available clinical guidelines to accurately diagnose patients with severe asthma vs difficult-to-treat asthma vs uncontrolled persistent asthma Neutral	Utilize available clinical guidelines to accurately diagnose patients with severe asthma vs difficult-to-treat asthma vs uncontrolled persistent asthma Disagree	Utilize available clinical guidelines to accurately diagnose patients with severe asthma vs difficult-to-treat asthma vs uncontrolled persistent asthma Strongly disagree
Differentiate between asthma phenotypes and endotypes and utilize biomarkers to guide asthma diagnosis and predict response to therapy	Differentiate between asthma phenotypes and endotypes and utilize biomarkers to guide asthma diagnosis and predict response to therapy Strongly agree	Differentiate between asthma phenotypes and endotypes and utilize biomarkers to guide asthma diagnosis and predict response to therapy Agree	Differentiate between asthma phenotypes and endotypes and utilize biomarkers to guide asthma diagnosis and predict response to therapy Neutral	Differentiate between asthma phenotypes and endotypes and utilize biomarkers to guide asthma diagnosis and predict response to therapy Disagree	Differentiate between asthma phenotypes and endotypes and utilize biomarkers to guide asthma diagnosis and predict response to therapy Strongly disagree
Utilize available clinical trial data and readily available biomarkers to select the most appropriate therapy for individual patients	Utilize available clinical trial data and readily available biomarkers to select the most appropriate therapy for individual patients Strongly agree	Utilize available clinical trial data and readily available biomarkers to select the most appropriate therapy for individual patients Agree	Utilize available clinical trial data and readily available biomarkers to select the most appropriate therapy for individual patients Neutral	Utilize available clinical trial data and readily available biomarkers to select the most appropriate therapy for individual patients Disagree	Utilize available clinical trial data and readily available biomarkers to select the most appropriate therapy for individual patients Strongly disagree
Utilize strategies to minimize the use of OCS in patients with severe asthma in order to reduce OCS-related adverse effects and improve quality of life	Utilize strategies to minimize the use of OCS in patients with severe asthma in order to reduce OCS-related adverse effects and improve quality of life Strongly agree	Utilize strategies to minimize the use of OCS in patients with severe asthma in order to reduce OCS-related adverse effects and improve quality of life Agree	Utilize strategies to minimize the use of OCS in patients with severe asthma in order to reduce OCS-related adverse effects and improve quality of life Neutral	Utilize strategies to minimize the use of OCS in patients with severe asthma in order to reduce OCS-related adverse effects and improve quality of life Disagree	Utilize strategies to minimize the use of OCS in patients with severe asthma in order to reduce OCS-related adverse effects and improve quality of life Strongly disagree
Describe strategies to effectively monitor patients with severe asthma in order to assess response to therapy, adherence to treatment, and opportunities to optimize therapy on an ongoing basis	Describe strategies to effectively monitor patients with severe asthma in order to assess response to therapy, adherence to treatment, and opportunities to optimize therapy on an ongoing basis Strongly agree	Describe strategies to effectively monitor patients with severe asthma in order to assess response to therapy, adherence to treatment, and opportunities to optimize therapy on an ongoing basis Agree	Describe strategies to effectively monitor patients with severe asthma in order to assess response to therapy, adherence to treatment, and opportunities to optimize therapy on an ongoing basis Neutral	Describe strategies to effectively monitor patients with severe asthma in order to assess response to therapy, adherence to treatment, and opportunities to optimize therapy on an ongoing basis Disagree	Describe strategies to effectively monitor patients with severe asthma in order to assess response to therapy, adherence to treatment, and opportunities to optimize therapy on an ongoing basis Strongly disagree

Question Title

* 9. William W. Busse, MD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 10. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 11. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 12. How would you rate the format of this activity?

Excellent

Average

Below average

Poor

Question Title

* 13. Would you be willing to participate in a post activity follow-up survey?

Yes